Pharmagreen Biotech Inc. (PHBI)
OTCMKTS · Delayed Price · Currency is USD
0.0020
0.00 (0.00%)
Mar 3, 2026, 11:55 AM EST
Pharmagreen Biotech Revenue
Pharmagreen Biotech had revenue of $828.00 in the quarter ending December 31, 2024, a decrease of -33.01%. This brings the company's revenue in the last twelve months to $3.00K, down -29.10% year-over-year. In the fiscal year ending September 30, 2024, Pharmagreen Biotech had annual revenue of $3.41K with 13.74% growth.
Revenue (ttm)
3.00K
Revenue Growth
-29.10%
P/S Ratio
506.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 3.41K | 412.00 | 13.74% |
| Sep 30, 2023 | 3.00K | - | - |
| Sep 30, 2022 | - | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | - | - | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mystic Holdings | 21.40M |
| Procyon | 4.98M |
| Opus Holdings | 758.68K |
| LiveWire Ergogenics | 571.68K |
| Herborium Group | 259.10K |
| Anything Technologies Media | 257.70K |
| CBD Life Sciences | 178.45K |
| Galexxy Holdings | 20.00K |